Recro to Report Year End 2019 Financial Results

Financial results

MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) a leading contract development and manufacturing organization (CDMO) with integrated solutions for the development, formulation, regulatory support, manufacturing and packaging of oral solid dose drug products, announced that it will report year end 2019 financial results on Wednesday, March 4, 2020.

Recro’s management team will host a conference call and audio webcast at 8:00 a.m. ET on Wednesday, March 4, 2020 to discuss the financial results and recent operational highlights.

To access the conference call, please dial (844) 243-4691 (local) or (225) 283-0379 (international) at least 10 minutes prior to the start time and refer to conference ID 4297426. A live audio webcast of the call will be available under “Events” in the Investor section of the Company’s website, https://ir.recropharma.com/events.

An archived webcast will be available on the Company’s website approximately two hours after the event and will be available for 30 days.

READ:  Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee